| scholarly article | Q13442814 |
| P50 | author | Vincenzo Mazzaferro | Q56380032 |
| Jean-Pierre Vartanian | Q60728893 | ||
| Carlo Battiston | Q40521585 | ||
| P2093 | author name string | Anne Dejean | |
| Simon Wain-Hobson | |||
| Michel Henry | |||
| Pascal Pineau | |||
| Agnès Marchio | |||
| Rodolphe Suspène | |||
| Minerva Cervantes-Gonzalez | |||
| Denise Guétard | |||
| Marie-Ming Aynaud | |||
| P2860 | cites work | Human APOBEC1 cytidine deaminase edits HBV DNA | Q21245048 |
| Population stratification of a common APOBEC gene deletion polymorphism | Q21563457 | ||
| An anthropoid-specific locus of orphan C to U RNA-editing enzymes on chromosome 22 | Q24292358 | ||
| APOBEC3 proteins mediate the clearance of foreign DNA from human cells | Q24294583 | ||
| Liver histology in patients with HBsAg negative anti-HBc and anti-HCV positive chronic hepatitis | Q60232583 | ||
| Helicobacter pylori infection triggers aberrant expression of activation-induced cytidine deaminase in gastric epithelium | Q80078384 | ||
| Recruitment and activation of naive T cells in the islets by lymphotoxin beta receptor-dependent tertiary lymphoid structure | Q80171529 | ||
| Effects of structural variations of APOBEC3A and APOBEC3B genes in chronic hepatitis B virus infection | Q84595302 | ||
| Restriction of foamy viruses by APOBEC cytidine deaminases | Q24299944 | ||
| The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA | Q24305266 | ||
| Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes | Q24534395 | ||
| Induction of APOBEC3 family proteins, a defensive maneuver underlying interferon-induced anti-HIV-1 activity | Q24677778 | ||
| Suppression of hepatitis B virus expression and replication by hepatitis C virus core protein in HuH-7 cells | Q27486067 | ||
| Hepatitis C Virus (HCV)-Induced Immunoglobulin Hypermutation Reduces the Affinity and Neutralizing Activities of Antibodies against HCV Envelope Protein | Q27486411 | ||
| Cancer-related inflammation | Q27860907 | ||
| Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts | Q28179446 | ||
| Species-specific exclusion of APOBEC3G from HIV-1 virions by Vif | Q28187133 | ||
| Hypermutation of HIV-1 DNA in the Absence of the Vif Protein | Q28204475 | ||
| Retroviral restriction by APOBEC proteins | Q28290721 | ||
| Specific expression of activation-induced cytidine deaminase (AID), a novel member of the RNA-editing deaminase family in germinal center B cells | Q28509339 | ||
| Cytidine deamination of retroviral DNA by diverse APOBEC proteins | Q28578747 | ||
| Cellular inhibitors of long interspersed element 1 and Alu retrotransposition. | Q30445599 | ||
| Genetic editing of HBV DNA by monodomain human APOBEC3 cytidine deaminases and the recombinant nature of APOBEC3G. | Q33402907 | ||
| Differences in APOBEC3G expression in CD4+ T helper lymphocyte subtypes modulate HIV-1 infectivity | Q33406252 | ||
| Extensive editing of both hepatitis B virus DNA strands by APOBEC3 cytidine deaminases in vitro and in vivo | Q33852042 | ||
| Human immunodeficiency virus type 1 DNA sequences genetically damaged by hypermutation are often abundant in patient peripheral blood mononuclear cells and may be generated during near-simultaneous infection and activation of CD4(+) T cells | Q33853620 | ||
| Effect of hepatitis B virus mutants on efficacy of vaccination | Q33903914 | ||
| Apolipoprotein B mRNA-editing protein induces hepatocellular carcinoma and dysplasia in transgenic animals | Q33985264 | ||
| Vaccine- and hepatitis B immune globulin-induced escape mutations of hepatitis B virus surface antigen | Q34269133 | ||
| Point mutations upstream of hepatitis B virus core gene affect DNA replication at the step of core protein expression | Q34301677 | ||
| Replicating hepatitis delta virus RNA is edited in the nucleus by the small form of ADAR1. | Q34381461 | ||
| Hepatitis B virus DNA is subject to extensive editing by the human deaminase APOBEC3C. | Q34649306 | ||
| Evidence for editing of human papillomavirus DNA by APOBEC3 in benign and precancerous lesions | Q34769157 | ||
| High-molecular-mass APOBEC3G complexes restrict Alu retrotransposition | Q35070356 | ||
| A read-ahead function in archaeal DNA polymerases detects promutagenic template-strand uracil. | Q35593823 | ||
| Lymphoid neogenesis in chronic inflammatory diseases. | Q36405080 | ||
| A single amino acid difference in the host APOBEC3G protein controls the primate species specificity of HIV type 1 virion infectivity factor | Q37094645 | ||
| Inflammation and cancer: how friendly is the relationship for cancer patients? | Q37316105 | ||
| Defining APOBEC3 expression patterns in human tissues and hematopoietic cell subsets | Q37333883 | ||
| Hepatitis C virus induces a mutator phenotype: enhanced mutations of immunoglobulin and protooncogenes | Q37356991 | ||
| APOBEC3G genetic variants and their influence on the progression to AIDS. | Q37567867 | ||
| Activation-induced cytidine deaminase acts as a mutator in BCR-ABL1-transformed acute lymphoblastic leukemia cells | Q38302008 | ||
| G-to-A hypermutation in hepatitis B virus (HBV) and clinical course of patients with chronic HBV infection | Q39853248 | ||
| Expression of activation-induced cytidine deaminase in human hepatocytes via NF-kappaB signaling | Q40150411 | ||
| Interferon-inducible expression of APOBEC3 editing enzymes in human hepatocytes and inhibition of hepatitis B virus replication | Q40275011 | ||
| Anti-viral protein APOBEC3G is induced by interferon-alpha stimulation in human hepatocytes. | Q40326926 | ||
| APOBEC3G cytidine deaminase inhibits retrotransposition of endogenous retroviruses. | Q40464899 | ||
| Recovery of APOBEC3-edited human immunodeficiency virus G->A hypermutants by differential DNA denaturation PCR. | Q40479794 | ||
| Inhibition of hepatitis B virus replication by APOBEC3G. | Q40576734 | ||
| Suppression of hepatitis B virus enhancer 1 and 2 by hepatitis C virus core protein | Q40688252 | ||
| APOBEC3G is a single-stranded DNA cytidine deaminase and functions independently of HIV reverse transcriptase | Q40899809 | ||
| RNA editing of hepatitis delta virus antigenome by dsRNA-adenosine deaminase | Q41206734 | ||
| The interferon-induced expression of APOBEC3G in human blood-brain barrier exerts a potent intrinsic immunity to block HIV-1 entry to central nervous system | Q42545124 | ||
| Foamy virus Bet proteins function as novel inhibitors of the APOBEC3 family of innate antiretroviral defense factors | Q42589642 | ||
| Loss of conserved cysteine residues in the attachment (G) glycoprotein of two human respiratory syncytial virus escape mutants that contain multiple A-G substitutions (hypermutations). | Q42673660 | ||
| Murine APOBEC1 is a powerful mutator of retroviral and cellular RNA in vitro and in vivo | Q42806825 | ||
| Constitutive expression of AID leads to tumorigenesis | Q42944928 | ||
| Enhanced expression of lymphomagenesis-related genes in peripheral blood B cells of chronic hepatitis C patients | Q43147236 | ||
| G to A hypermutation of TT virus. | Q43170181 | ||
| Antigenic structure of the human respiratory syncytial virus G glycoprotein and relevance of hypermutation events for the generation of antigenic variants | Q44438075 | ||
| Processive AID-catalysed cytosine deamination on single-stranded DNA simulates somatic hypermutation | Q44486460 | ||
| The Vif Protein of HIV Triggers Degradation of the Human Antiretroviral DNA Deaminase APOBEC3G | Q44653976 | ||
| Chronic hepatitis in patients with active hepatitis B virus and hepatitis C virus combined infections: a histological study | Q44776943 | ||
| Comparison of the differential context-dependence of DNA deamination by APOBEC enzymes: correlation with mutation spectra in vivo | Q44799102 | ||
| Role of inducible bronchus associated lymphoid tissue (iBALT) in respiratory immunity | Q45018410 | ||
| Mutation of the "a" determinant of HBsAg with discordant HBsAg diagnostic kits | Q45051951 | ||
| APOBEC3G upregulation by alpha interferon restricts human immunodeficiency virus type 1 infection in human peripheral plasmacytoid dendritic cells | Q45397134 | ||
| Extensive editing of a small fraction of human T-cell leukemia virus type 1 genomes by four APOBEC3 cytidine deaminases | Q45426508 | ||
| Frequent integration of precore/core mutants of hepatitis B virus in human hepatocellular carcinoma tissues | Q45743231 | ||
| Altered antigenicity of 'a' determinant variants of hepatitis B virus | Q45759805 | ||
| Vaccine-induced escape mutant of hepatitis B virus | Q45860147 | ||
| A novel mouse model of hepatocarcinogenesis triggered by AID causing deleterious p53 mutations. | Q46255308 | ||
| Organ-specific profiles of genetic changes in cancers caused by activation-induced cytidine deaminase expression | Q46378599 | ||
| Programmed death 1 expression during antiviral treatment of chronic hepatitis B: Impact of hepatitis B e-antigen seroconversion. | Q46433843 | ||
| Activation-induced cytidine deaminase links between inflammation and the development of colitis-associated colorectal cancers | Q46437306 | ||
| Global effect of PEG-IFN-alpha and ribavirin on gene expression in PBMC in vitro | Q47190483 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 5 | |
| P921 | main subject | hepatitis B | Q6853 |
| liver cirrhosis | Q147778 | ||
| P304 | page(s) | e1000928 | |
| P577 | publication date | 2010-05-27 | |
| P1433 | published in | PLOS Pathogens | Q283209 |
| P1476 | title | Massive APOBEC3 editing of hepatitis B viral DNA in cirrhosis | |
| P478 | volume | 6 |
| Q38261749 | AID and APOBEC deaminases: balancing DNA damage in epigenetics and immunity |
| Q28081195 | APOBEC3 Interference during Replication of Viral Genomes |
| Q36263411 | APOBEC3 Proteins in Viral Immunity. |
| Q38949590 | APOBEC3A catabolism of electroporated plasmid DNA in mouse muscle. |
| Q50926343 | APOBEC3B and IL-6 form a positive feedback loop in hepatocellular carcinoma cells. |
| Q39245074 | APOBEC3B can impair genomic stability by inducing base substitutions in genomic DNA in human cells. |
| Q34529142 | APOBEC4 Enhances the Replication of HIV-1. |
| Q38394187 | APOBECs and virus restriction |
| Q42235285 | Activation-induced cytidine deaminase is dispensable for virus-mediated liver and skin tumor development in mouse models |
| Q38258081 | Age-Dependent Immune Events during HBV Infection from Birth to Adulthood: An Alternative Interpretation |
| Q42216224 | Altered mRNA levels of MOV10, A3G, and IFN-α in patients with chronic hepatitis B. |
| Q28713968 | An ancient history of gene duplications, fusions and losses in the evolution of APOBEC3 mutators in mammals |
| Q30502490 | Analysis of a single-stranded DNA-scanning process in which activation-induced deoxycytidine deaminase (AID) deaminates C to U haphazardly and inefficiently to ensure mutational diversity |
| Q37586253 | Association between polymorphisms of the APOBEC3G gene and chronic hepatitis B viral infection and hepatitis B virus-related hepatocellular carcinoma |
| Q36054401 | Association of Hepatitis B Virus Covalently Closed Circular DNA and Human APOBEC3B in Hepatitis B Virus-Related Hepatocellular Carcinoma |
| Q26781812 | Associations between activation-induced cytidine deaminase/apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like cytidine deaminase expression, hepatitis B virus (HBV) replication and HBV-associated liver disease (Review) |
| Q54264672 | Asymmetric Modification of Hepatitis B Virus (HBV) Genomes by an Endogenous Cytidine Deaminase inside HBV Cores Informs a Model of Reverse Transcription. |
| Q26766386 | Cancer Evolution-Development: experience of hepatitis B virus-induced hepatocarcinogenesis |
| Q36023244 | Cancer, Warts, or Asymptomatic Infections: Clinical Presentation Matches Codon Usage Preferences in Human Papillomaviruses |
| Q38769680 | Complete Spectrum of CRISPR/Cas9-induced Mutations on HBV cccDNA. |
| Q39108891 | Concerted action of activation-induced cytidine deaminase and uracil-DNA glycosylase reduces covalently closed circular DNA of duck hepatitis B virus |
| Q34137297 | Control of hepatitis B virus replication by interferons and Toll-like receptor signaling pathways |
| Q90481054 | Correlation of APOBEC3G expression with liver function indexes of patients with chronic hepatitis B and comparison in chronic hepatitis B, liver cirrhosis and liver cancer |
| Q92675146 | Deamination hotspots among APOBEC3 family members are defined by both target site sequence context and ssDNA secondary structure |
| Q39619772 | Double-stranded RNA adenosine deaminase ADAR-1-induced hypermutated genomes among inactivated seasonal influenza and live attenuated measles virus vaccines |
| Q34804205 | Efficient deamination of 5-methylcytidine and 5-substituted cytidine residues in DNA by human APOBEC3A cytidine deaminase |
| Q39627532 | Erroneous identification of APOBEC3-edited chromosomal DNA in cancer genomics |
| Q34137458 | Evolution of the primate APOBEC3A cytidine deaminase gene and identification of related coding regions |
| Q42967810 | Factors predicting occurrence and prognosis of hepatitis-B-virus-related hepatocellular carcinoma |
| Q42251194 | Full genome ultra-deep pyrosequencing associates G-to-A hypermutation of the hepatitis B virus genome with the natural progression of hepatitis B. |
| Q24305160 | Genetic editing of herpes simplex virus 1 and Epstein-Barr herpesvirus genomes by human APOBEC3 cytidine deaminases in culture and in vivo |
| Q57025283 | Genomic Analyses from Non-invasive Prenatal Testing Reveal Genetic Associations, Patterns of Viral Infections, and Chinese Population History |
| Q49987475 | Genomic Destabilization Triggered by Replication Stress during Senescence. |
| Q64092985 | Genotoxic stress increases cytoplasmic mitochondrial DNA editing by human APOBEC3 mutator enzymes at a single cell level |
| Q37864117 | HBV life cycle and novel drug targets |
| Q37254285 | HLA-DP polymorphisms affect the outcomes of chronic hepatitis B virus infections, possibly through interacting with viral mutations |
| Q40150522 | Heat shock proteins stimulate APOBEC-3-mediated cytidine deamination in the hepatitis B virus |
| Q37591195 | Hepatitis B virus X protein is capable of down-regulating protein level of host antiviral protein APOBEC3G. |
| Q36280421 | Hepatitis B virus genotype, mutations, human leukocyte antigen polymorphisms and their interactions in hepatocellular carcinoma: a multi-centre case-control study |
| Q28545012 | Host APOBEC3G protein inhibits HCV replication through direct binding at NS3 |
| Q39561115 | Host apolipoprotein B messenger RNA-editing enzyme catalytic polypeptide-like 3G is an innate defensive factor and drug target against hepatitis C virus |
| Q33982561 | Human APOBEC3 induced mutation of human immunodeficiency virus type-1 contributes to adaptation and evolution in natural infection |
| Q34974240 | Human APOBEC3A isoforms translocate to the nucleus and induce DNA double strand breaks leading to cell stress and death |
| Q24625056 | Human LINE-1 restriction by APOBEC3C is deaminase independent and mediated by an ORF1p interaction that affects LINE reverse transcriptase activity |
| Q41308580 | Human Tribbles 3 protects nuclear DNA from cytidine deamination by APOBEC3A. |
| Q35850930 | Hypermutation of ApoB mRNA by rat APOBEC-1 overexpression mimics APOBEC-3 hypermutation |
| Q92767464 | Hypoxia-induced human deoxyribonuclease I is a cellular restriction factor of hepatitis B virus |
| Q39327457 | Immune Evasion Strategies during Chronic Hepatitis B and C Virus Infection |
| Q33694570 | Immunoglobulin somatic hypermutation by APOBEC3/Rfv3 during retroviral infection |
| Q39645012 | In Vivo Examination of Mouse APOBEC3- and Human APOBEC3A- and APOBEC3G-Mediated Restriction of Parvovirus and Herpesvirus Infection in Mouse Models. |
| Q40929061 | Increased expression and dysregulated association of restriction factors and type I interferon in HIV, HCV mono- and co-infected patients. |
| Q64097659 | Induction of APOBEC3B cytidine deaminase in HTLV-1-infected humanized mice |
| Q37272140 | Interleukin-1 and tumor necrosis factor-α trigger restriction of hepatitis B virus infection via a cytidine deaminase activation-induced cytidine deaminase (AID) |
| Q37899341 | Intracellular defenses against HIV, viral evasion and novel therapeutic approaches |
| Q38961370 | Lethal mutagenesis of foot-and-mouth disease virus involves shifts in sequence space |
| Q26744497 | Links between Human LINE-1 Retrotransposons and Hepatitis Virus-Related Hepatocellular Carcinoma |
| Q57173759 | Modeling the Embrace of a Mutator: APOBEC Selection of Nucleic Acid Ligands |
| Q36228069 | Molecular basis of the attenuated phenotype of human APOBEC3B DNA mutator enzyme |
| Q36978561 | Molecular determinants of hepatitis B and D virus entry restriction in mouse sodium taurocholate cotransporting polypeptide |
| Q27686923 | Molecular mechanisms underlying occult hepatitis B virus infection |
| Q56957525 | Mutant spectra in virus behavior |
| Q38997194 | Polymorphic APOBEC3 modulates chronic hepatitis B in Moroccan population |
| Q34264608 | Quantification of unintegrated HIV-1 DNA at the single cell level in vivo |
| Q36598091 | RNA editing of hepatitis B virus transcripts by activation-induced cytidine deaminase |
| Q38194061 | Recent insights into hepatitis B virus-host interactions. |
| Q40076776 | Roles of APOBEC3A and APOBEC3B in Human Papillomavirus Infection and Disease Progression |
| Q33558248 | Self-cytoplasmic DNA upregulates the mutator enzyme APOBEC3A leading to chromosomal DNA damage |
| Q34720629 | Somatic hypermutation of human mitochondrial and nuclear DNA by APOBEC3 cytidine deaminases, a pathway for DNA catabolism |
| Q35029955 | Somatic mutations, viral integration and epigenetic modification in the evolution of hepatitis B virus-induced hepatocellular carcinoma |
| Q58866812 | Strategy of Human Cytomegalovirus To Escape Interferon Beta-Induced APOBEC3G Editing Activity |
| Q35593692 | TGF-β suppression of HBV RNA through AID-dependent recruitment of an RNA exosome complex |
| Q37175149 | The MOV10 helicase inhibits LINE-1 mobility. |
| Q90596932 | The Solo Play of TERT Promoter Mutations |
| Q95936549 | The evolution and clinical impact of hepatitis B virus genome diversity |
| Q55363233 | The rabbit as an orthologous small animal model for APOBEC3A oncogenesis. |
| Q41812539 | The role of cytidine deaminases on innate immune responses against human viral infections. |
| Q34733579 | Uracil DNA glycosylase counteracts APOBEC3G-induced hypermutation of hepatitis B viral genomes: excision repair of covalently closed circular DNA. |
| Q27013917 | Viral quasispecies evolution |
| Q33718267 | Virus-related liver cirrhosis: molecular basis and therapeutic options |
Search more.